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Abstract 
Background and Purpose: Aeration in the nasal cavity and paranasal 
sinus (NCPS) was investigated during the course of proton therapy (PT), 
and the influence of aeration on the dose distribution was determined. 
Material and Methods: Twenty patients with NCPS cancer (10 nasal 
cavity, 10 paranasal sinus) were analyzed. All the patients received a total 
proton beam irradiation dose of 38–78.4 Gray equivalents (GyE). Two to 
five CT examinations were performed during the course of treatment. The 
aeration ratio inside the cavity/sinus was calculated for each CT 
observation. Moreover, a simulation study supposing that the first treatment 
plan had been continued until the end of treatment was performed using the 
subsequent CT findings. 
Results: The aeration ratio was increased in 18 patients. The largest 
increase was from 15% to 82%. Three patients had a simulated maximum 
cumulative dose in the brainstem of beyond 60 GyE, while 10 patients had 
a simulated maximum cumulative dose in the optic chiasm of beyond 50 
GyE. The shortest simulated time period to reach the dose limitation was 
21 days. 
Conclusions: Aeration in the NCPS is altered during the course of PT 
treatment and can greatly alter the dose distribution in the brainstem and 
optic chiasm. 
Introduction 
Proton therapy (PT) for cancer treatment was developed in the 1950s. A 
proton beam enables a rapidly increasing dose at the end of its beam range 
[1]. Because of its excellent dose escalation characteristics, PT is very 
useful for the treatment of many types of cancer, and the number of 
facilities for PT has been increasing worldwide in recent years. For nasal 
cavity or paranasal sinus (NCPS) cancers, PT enables the delivery of a high 
irradiation dose to the tumor without exceeding the tolerant irradiation dose 
to close critical organs, such as the brainstem and optic chiasm, and has 
been recognized as a useful treatment tool [2-5]. 
        The NCPS region contains complicated structures such as bone, 
mucosa, tumor tissue, collected fluid, and air, which can alter the different 
proton beam ranges. Moreover, the ratios and geometrical distributions of 
these components are largely altered during the course of treatment in most 
patients. Especially, changes in the mucosal thickness, tumor volume, and 
collected fluid can contribute to the amount of aeration inside the NCPS. 
These changes can alter the proton beam range to a large degree and in an 
inhomogeneous manner during the course of treatment. 
        In particular, increases in aeration as a result of tumor shrinkage 
should extend the proton beam range to a greater depth. Physicians are 
frequently obliged to irradiate critical organs at the maximum tolerable 
dose during the treatment of advanced NCPS cancer patients. Therefore, 
slight dose distribution changes to critical organs are associated with a risk 
of inducing severe side effects. However, to our knowledge, no detailed 
reports have investigated changes in aeration and dose distribution to 
critical organs in NCPS cancer patients undergoing treatment with PT. 
        We calculated the amount of aeration inside the NCPS 
quantitatively and investigated the changes in aeration during the course of 
PT. Moreover, we conducted a simulation study under the assumption that 
the first treatment plan had been continued until the end of treatment using 
subsequent CT findings obtained during the course of treatment. Then, we 
investigated the changes in the dose distribution to critical organs located 
beneath the tumor. 
 
Materials and Methods 
We analyzed 20 consecutive adult NCPS cancer patients (31–87 years old, 
13 men and 7 women) examined between December 2009 and March 2013. 
The primary site was the nasal cavity in 10 patients, the maxillary sinus in 
6, and the ethmoid sinus in 4. The pathological findings were squamous 
cell carcinoma (SCC) in 8 patients, melanoma in 5, neuroblastoma in 3, 
adenoid cystic carcinoma in 1, cylindrical cell carcinoma in 1, poorly 
differentiated carcinoma in 1, and small cell carcinoma in 1. Visually, the 
primary tumor fully occupied the NCPS in 13 patients, occupied more than 
half of the NCPS in 4 patients, and occupied less than half of the NCPS in 
3 patients. The number of CT examinations performed for dose planning 
during the course of treatment was 2–5, including first planning CT 
examination. The timing of the CT examinations was decided based on 
routine disease checks (at an interval of about 2–3 weeks), visually 
observed changes in the intranasal condition, cumulative irradiation doses 
to critical organs, or the physician’s medical decision. 
PT was performed in all the patients. Uniform scanning was used 
for the proton beam. In detail, a broad proton beam using the 
double-scattering method was prepared for the treatment. The beam 
delivery system created a homogeneous dose distribution at the prescribed 
dose using the spread-out Bragg peak of the proton beam. The total 
irradiation dose was 38 Gray equivalents (GyE) in 1 patient who had 
previously received X-ray radiotherapy and 56–78 GyE in the other 19 
patients (Table S1). The number of beam directions was 2 or 3 (28 anterior 
direction (0-30 degree), 4 anterolateral (31-60 degree), 6 lateral (61-90 
degree), and 6 posterolateral (more than 91 degree)) at the first planning. 
The dose distribution was calculated using VQA plan, Ver. 2.0 (Hitachi, 
Ltd). Treatment planning was modified 1–4 times during the treatment 
course in 19 patients, and only 1 patient received a constant irradiation 
field. 
 
Aeration calculation study 
The data analysis was performed using the Dr. View/LINUX image 
analysis software system (AJS Inc., Tokyo, Japan), as shown in Figure S1. 
First, image registration of subsequent CT images was performed using the 
first planning CT as a reference. For image registration, we used a 
three-dimensional rigid registration algorithm developed by Maes et al [6]. 
The rigid registration used a mutual information algorithm for which the 
image intensity values of the corresponding voxel pairs reached a 
maximum if the images were geometrically aligned. The registration error 
was estimated to be a maximum of 1–2 mm [6]. The registration result was 
visually checked, and none of the patients required manual adjustments in 
this study. Second, the sinus in which the tumor existed was manually 
contoured during the first planning CT examination. We defined the sinus 
in which the tumor existed as the main sinus in this study. Next, an image 
of the main sinus was constructed by subtracting the outside of the 
contoured area from the first planning CT image. For the subsequent CT 
image, the same contoured area was applied and the main sinus image was 
constructed in the same way (Fig. S1).  
Images were constructed for bone, soft tissue, and air. Then, the 
volume of the real main sinus (A) was calculated by subtracting the bone 
tissue component from the original volume. The aeration ratio of the main 
sinus was calculated using (A) and the volume of the air (B), as shown by 
the equation below: 
Aeration ratio = (B/A) × 100 (%). 
The aeration ratio of the other sinuses was also calculated in the same way. 
 
Simulation study 
We performed a simulation study of the dose distribution to the critical 
organs supposing that the first treatment plan had been used throughout the 
course of treatment. We applied the same irradiation conditions (beam 
energy, isocenter, irradiation field, bolus, and spread-out Bragg peak 
length) used during the first treatment plan to the subsequent CT. The dose 
distribution was calculated using a pencil beam algorithm. The brainstem, 
optic chiasm, contralateral retina, and brain were manually contoured on 
each CT, and a comparative study was performed. 
 
Analysis 
We calculated the aeration ratio, simulated irradiation dose of the brainstem, 
optic chiasm, retina, brain, and clinical target volume (CTV). Data is 
expressed as the mean value ± standard deviation. The cumulative dose 
was calculated as the biological effective dose of 2 GyE (α/β = 3). The dose 
limit was set at 60 GyE for the brainstem and 50 GyE for the optic chiasm 
[7, 8]. The dose limit for the retina was set at 45 GyE for the whole organ, 
and for the brain was set at 60 GyE for 1/3 of the volume [8]. In the 
analysis of the irradiation dose of the CTV, we calculated the dose received 
by 95% of the target volume (D95%) in each CT, then examined the 
alteration of the dose coverage during the treatment course. A paired t-test 
of the aeration ratio was performed between the first planning CT and last 
CT during the treatment course. 
 
Results 
The aeration change in the main sinus ranged from −8% to 67% (18% ± 
19%). The aeration ratio increased in 18 patients, and the values for the last 
CT examination were higher than those for the first planning CT 
examination (P = 0.0002). The values in 11 of the 18 patients increased 
more than twofold, with a doubling time of 38 days. The largest increase 
was from 15% to 82%. In contrast, the aeration change in the other sinuses 
ranged from −27% to 20% (0% ± 12%). The aeration ratio increased in 12 
patients, decreased in 7 patients, and did not change in 1 patient. Overall, 
the aeration in the other sinuses did not change remarkably (Fig. 1). 
Three patients had a simulated maximum cumulative dose to the 
brainstem of beyond 60 GyE. The shortest period during which the 
cumulative dose would have reached 60 GyE was 38 days. Ten patients had 
a simulated maximum cumulative dose to the optic chiasm of beyond 50 
GyE. The shortest period during which the cumulative dose would have 
reached 50 GyE was 21 days. The maximum cumulative dose to the retina 
was 3.9 GyE and much less than 45 GyE (Fig. 2). Regarding the brain, all 
patients showed the cumulative dose as 0 GyE. In contrast, the D95% of 
the CTV was changed 102 ± 4% during a total of 45 times of the 
subsequent CT, and the lowest value was 91% compared to the first 
planning CT.  
Figure 3 shows an example of a simulation in which the dose 
distribution in the brainstem and optic chiasm would have changed as the 
aeration progressed. 
 
Discussion 
The appearance of NCPS changes rapidly and considerably during the 
course of radiation treatment. The presence of a tumor sometimes creates 
an obstacle to mucus outflow; thus, massive fluid collection is 
indistinguishably intermixed with the tumor in the NCPS. In general, the 
volume of a radio-sensitive tumor decreases rapidly. As the tumor volume 
is reduced, the blockade is loosened and the outflow of the collected fluid 
occurs, allowing aeration to progress rapidly. On the other hand, the size of 
a radio-resistant tumor decreases slowly or occasionally increases. Mucosal 
thickening as an early side effect of irradiation may progress. Accordingly, 
the alteration of the aeration in the NCPS is difficult to predict. In our study, 
18 of the 20 patients exhibited an increase in aeration. In contrast, the other 
sinuses did not show any large changes. These results indicate that the 
sinus in which the tumor exists tends to undergo changes in its components 
as a result of proton beam irradiation, and factors promoting an increase in 
aeration had a greater influence than those with an opposite influence. 
Patients whose aeration ratio increased abruptly had a common 
characteristic. Figure S2 shows the magnetic resonance imaging (MRI) 
findings obtained before the start of treatment in cases with a dramatic 
change in aeration during the course of treatment (from 15% to 82% in case 
17, and from 15% to 58% in case 19). Both patients had a large quantity of 
fluid collected in the NCPS, probably because of the obstruction of the 
sinus by the tumor. The shrinkage of the tumor undoubtedly led to an 
outflow of the collected fluid, resulting in the rapid progression of aeration. 
Thus, patients with a large quantity of fluid collection should be checked 
more carefully. 
         The dose distribution is calculated by the stopping power of the 
proton beams at each point and the strength of scatter [9]. The stopping 
power is regulated by the electron density for various body tissues in PT. 
The electron density of an organ is closely related to its Hounsfield Unit 
(HU) of the CT image. Schaffner et al. reported that the stopping power 
and HU were directly proportional to each other for homogeneous soft 
tissue [10]. Therefore, it is easily predicted that when a proton beam passes 
through an area where a tumor or fluid collection has been converted to air 
the range shift is greater than when there has just been a change in the size 
or structure of a tumor. Moreover, a few reports have investigated the 
influence of heterogeneous structures on the dose distribution during PT for 
head and neck cancers. Bueno et al. reported that the higher the level of 
tissue inhomogeneity, the larger the discrepancy of the dose distribution 
between a pencil beam and the Monte Carlo algorithm [11]. Aeration 
change in NCPS not only causes proton beam range shift, but also causes 
uncertain dose distribution to the critical organs.  
On the other hand, dose distributions to the retina, brain or CTV 
were not largely changed. However, only 1 patient showed rapid increase 
of cumulative dose to the retina, 29 days (52.5 GyE) after treatment started 
(case 12). This patient received the proton beams from the anterior and 
lateral directions. The aeration ratio was changed from 10 to 51% on the 
CT 29 days (52.5 GyE) after treatment started. Even though the cumulative 
dose did not reach the tolerant dose in this patient, aeration and eyesight 
should be more carefully checked in patients who receive the proton beams 
from the lateral direction. The reason we examined the contralateral retina 
is because irradiation to the ipsilateral retina is often unavoidable during 
treatment and some patients received PT on condition of conserving the 
contralateral eyesight even if ipsilateral eyesight might be lost. However, it 
goes without saying that we protect the ipsilateral retina as much as 
possible by adjusting the field-size. Because of the excellent stopping 
power of the proton beams, the irradiated volume to the brain was 
originally little, even though the distal end of the proton beam was 
prolonged. The beam range shift should influence the dose distribution of 
the CTV. However, we set the margin as 5-10 mm in all patients, which 
could avoid unpredicted dose decrease to the CTV. 
Only a few reports have investigated the dose distribution change 
derived from anatomical change when using PT for head and neck cancers. 
Kraan et al. reported the average dose reduction of CTV was about 2% and 
dose increase in critical organs was less than 1 GyE [12]. However, as that 
increase had large variations, they suggested repeat imaging, dose 
recalculation, and, if required, adaptive planning to ensure sufficient target 
coverage and to avoid unwanted exposure of critical organs. Simone et al. 
compared intensity-modulated proton radiotherapy (IMPT) and adaptive 
IMPT for head and neck cancers, and reported that although dose reduction 
of critical organs in adaptive IMPT was less clinically significant, care 
must be taken to account for these changes or to otherwise ensure accuracy 
of the beam range because proton plans are sensitive to interfractional 
changes in tumor volume and patient anatomy [13]. In recent years, 
adaptive treatment planning for head and neck cancers has increased, 
mostly in X-ray radiotherapy [14, 15]. Although dose distribution change 
for critical organs was not so large in the NCPS cancer patients as a whole, 
some patients in our study showed unexpected change which should not be 
overlooked. We propose that repeat imaging and dose recalculation is 
necessary, and that if adaptive treatment planning can be performed it 
should be positively adopted to avoid unexpected higher dose distribution 
to critical organs as suggested by previous studies [12, 13]. 
As shown in Figures 1 and 2, aeration begins to increase within 
10 days after the start of treatment and continues to increase for 30–40 days. 
The irradiation dose to the brainstem and optic chiasm begins to increase 
after approximately 10 days and becomes prominent at around 20–30 days. 
One patient whose simulated dose distribution to the brainstem increased 
dramatically had a maximum cumulative dose of 22% in 20 days, 
increasing to 83% in 48 days (case 1). Interestingly, all 3 patients whose 
maximum cumulative dose to the brainstem increased beyond 60 GyE 
would not have reached a dose of 60 GyE unless a rapid increase in the 
irradiation dose had occurred during the final stage of treatment. Although 
the change in the dose distribution in the optic chiasm was not as dramatic 
as that in the brainstem, one patient with a large increase in the simulated 
dose distribution in the optic chiasm had a maximum cumulative dose of 39 
GyE in 20 days, increasing to 111 GyE in 48 days (case 1). The most 
important topic in clinical settings is the timing of re-planning. Our 
simulation study suggests that re-planning should be conducted within 20 
days after the start of treatment. 
The significance of this study is that it is the first report to show 
the importance of aeration changes quantitatively. On the other hand, our 
study has some limitations. We examined cancer patients with a variety of 
pathological findings, similar to most previous studies on NCPS cancers [2, 
16-19], because NCPS cancer is rare and accounts for only 5% of all 
head-and-neck cancers [20]. Also, the total irradiation dose or timing of the 
CT examination was not necessarily constant in our retrospective analysis. 
Utilizing aeration conditions in real-time treatment planning is difficult 
because our institute uses a passive planning system, rather than an 
adaptive one. Under these conditions, analyzing which kinds of tumors 
have a risk of an unexpected high dose distribution to critical organs is 
quite difficult. 
In reality, none of the patients suffered severe side effects after 
treatment because the treatment plan was altered several times during the 
course of treatment. However, the risk of severe side effects is always 
unavoidable in the treatment of NCPS cancer, in which critical organs are 
always located close to the tumor. The present simulation supposed that the 
first treatment plan had been continued until the end of treatment using 
subsequent CT findings obtained during the course of treatment. While this 
is a hypothetical study, we propose that re-planning should be conducted 
within 20 days after the start of treatment based on data showing when the 
cumulative dose to critical organs first reached the maximum tolerable dose. 
In addition, patients with massive fluid collection should be carefully 
observed because of the possibility of a rapid change in the proton beam 
depth. 
  
Figure legends  
Figure 1. Alteration of aeration ratio. 
(a): main sinus, (b): other sinuses. Red dot line represents regression line 
from all data. 
 
Figure 2. Cumulative dose of the brainstem, optic chiasm and retina: (a) 
brainstem, (b) optic chiasm, (c) retina. The cumulative dose was calculated 
as a biological effective dose of 2 GyE (α/β=3). The maximum cumulative 
dose was calculated in the brain stem and optic chiasm, and the irradiation 
dose to the whole organ was calculated in the retina. Dotted lines represent 
the dose limit. 
 
Figure 3. Alteration of dose distribution.  
Left image: first plan. Right image: simulation study which first treatment 
plan is applied to the subsequent CT. 
(a) Melanoma in the nasal cavity. As aeration of the nasal cavity and 
maxillary sinus increases, dose distribution of the brainstem is 
simulated to be increased (case 4). 
(b) SCC in the ethmoid sinus. As aeration of the ethmoid and frontal sinus 
increases, high irradiation area is simulated to shift toward the optic 
chiasm (case 18). Yellow line: optic nerve. White line: optic chiasm. 
 
Figure S1. Method for calculating the aeration ratio. 
Images from the first and subsequent (second and third) CT examinations 
are shown from the top.  
①  Image registration is performed using the first CT as a reference.  
②  Contouring of the main sinus slice-by-slice using the first CT. 
③  The contoured area is placed on the CT. The contoured area created 
using the first CT is also applied for the subsequent CT.  
④  An image of the main sinus is constructed by subtracting the outside of 
the contoured area from the original CT. 
 
Figure S2. MRI and dose distribution. 
Left image: T2 weighted image before treatment. Middle image: first plan. 
Right image: simulation study which first treatment plan is applied to the 
last CT. 
(a) SCC in the ethmoid sinus (T) and massive fluid collection in the left 
maxillary sinus (F). Amount of fluid collection is reduced, and dose 
distribution of the brainstem and cerebellum is simulated to be 
increased (case 17). 
(b) SCC in the nasal cavity (T) and massive fluid collection in the right 
maxillary sinus (F). Amount of fluid collection is reduced, and dose 
distribution of the brainstem is simulated to be increased (case 19). 
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